Holdings
First Trust NYSE Arca Biotechnology Index Fund
As of Jun 30, 2026, First Trust NYSE Arca Biotechnology Index Fund reported 29 positions worth US$2.74B. Largest: Corcept Therapeutics Incorporated, Neogenomics, Inc. and Veracyte, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Corcept Therapeutics Incorporated | 1.81M | US$157M | −340K | Jun 30, 2026 |
| Neogenomics, Inc. | 9.87M | US$144M | +3.74M | Jun 30, 2026 |
| Veracyte, Inc. | 2.44M | US$143M | +523K | Jun 30, 2026 |
| Bruker Corporation | 2.02M | US$122M | +538K | Jun 30, 2026 |
| Alkermes Plc | 2.28M | US$119M | −444K | Jun 30, 2026 |
| Illumina, Inc. | 628K | US$110M | +55,874 | Jun 30, 2026 |
| Krystal Biotech, Inc. | 293K | US$109M | −15,468 | Jun 30, 2026 |
| Natera, Inc. | 393K | US$107M | +48,987 | Jun 30, 2026 |
| Axsome Therapeutics, Inc. | 426K | US$104M | −95,756 | Jun 30, 2026 |
| Neurocrine Biosciences, Inc. | 589K | US$99.2M | −5,079 | Jun 30, 2026 |